
Relmada Therapeutics, Inc.
RLMDHealthcare|Biotechnology|US
$3.90
+0.13 (+3.45%)
DCF Value
$0.05
Tangible Book / Share
$1.84
Cash / Share
$1.94
Next Earnings Report
Nov 12, 2026
EPS est. -$0.14
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest May 13, 2026 (S-3ASR). Possible dilution.
Upcoming Data Readouts (1)
Nov 2027
Est. completion
P2Non Muscle Invasive Bladder Cancer
A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC
NCT06663137n=70
Recent Press Releases
Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
Nov 4, 2026 · GlobeNewsWire
Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
Nov 3, 2026 · GlobeNewsWire
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Sep 1, 2026 · GlobeNewsWire
SEC Filings (65)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Sep 8, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 28, 2026 | 8-K | Material event | DocumentIndex |
| Jun 22, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 18, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 9, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 28, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | S-3ASR | Shelf registration | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 4, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 17, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 17, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 9, 2026 | EFFECT | DocumentIndex | |
| Apr 9, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 6, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 3, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 20, 2026 | 8-K | Material event | DocumentIndex |
| Mar 19, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 9, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 12, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 6, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Dec 15, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2025 | 8-K | Material event | DocumentIndex |
| Nov 5, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 4, 2025 | FWP | DocumentIndex | |
| Nov 4, 2025 | 8-K | Material event | DocumentIndex |
| Sep 17, 2025 | 8-K | Material event | DocumentIndex |
| Sep 16, 2025 | 8-K | Material event | DocumentIndex |
| Sep 10, 2025 | 8-K | Material event | DocumentIndex |